TY - JOUR
T1 - Behavior of epidermolysis bullosa fibroblasts in a hydrated collagen lattice
AU - Eisen, Arthur Z.
AU - Pentland, Alice P.
AU - Bauer, Eugene A.
AU - Goldberg, Gregory I.
N1 - Funding Information:
Manuscript received October 2, 1986; accepted for publication December 5, 1986. T his study was supported by United States Public Health Service grants AM 12129, AM 19537, TO-AM 07284, and in part by the Monsanto Corn pany/Washington University Biomedical Research Agreement and the Washington University/D.E.B.R.A. Center for Research and Therapy of Epidermolysis Bullosa. * A preliminary report of this work was presented at the Joint International Meeting of the European Society for Dermatological Research and The Society for Investigative Dermatology, Inc., Geneva, Switzerland, June 22-26, 1986 0 Invest Dermatol 87:138, 1986). Reprint requests to: Arthur Z. Eisen, M. D., Division of Dermatology, Ca mpus Box 8123, Washington University School of Medicine, St. Louis, Missouri 63110. Abbreviations: DDEB: dominant dystrophic epidermolysis bullosa DEBS: dominant epidermolysis bullosa simplex DMEM: Dulbecco's modified Eagle's medium EB: epidermolysis bullosa E LISA: enzyme-linked immunoabsorbent assay RDEB: recessive dystrophic epidermolysis bullosa
PY - 1987/6
Y1 - 1987/6
N2 - To determine if an altered ability to contract a hydrated collagen lattice is characteristic of fibroblasts from patients with recessive dystrophic epidermolysis bullosa (RDEB), we examined contraction by fibroblasts from normal subjects and patients with RDEB, dominant dystrophic epidermolysis bullosa (DDEB), and dominant epidermolysis bullosa simplex (DEBS). An extremely broad range of contractility (normal, poor, and hypercontraction) was observed in all types of epidermolysis bullosa (EB). When contraction in control fibroblasts was defined as the mean ± 2 SD, (all control values were within this range) and the data were analyzed by the chi-square test, only 32% of EB cells fell within this range, with 47% poorly contractile and 21% hypercontractile. These data, derived from 34 patients, indicate that no single genetic defect resulting in altered contractility in the 3 distinct types of EB is likely. Neither cell viability, collagenase expression, nor PGE2 synthesis as correlated with gel contraction in any group. Indomethacin had no effect on contraction in RDEB. It is possible that the genetic defects in EB cause blister formation in vivo and may lead in some way to an abnormal interaction of fibroblasts with the extracellular matrix resulting in an altered collagen lattice contraction in vitro.
AB - To determine if an altered ability to contract a hydrated collagen lattice is characteristic of fibroblasts from patients with recessive dystrophic epidermolysis bullosa (RDEB), we examined contraction by fibroblasts from normal subjects and patients with RDEB, dominant dystrophic epidermolysis bullosa (DDEB), and dominant epidermolysis bullosa simplex (DEBS). An extremely broad range of contractility (normal, poor, and hypercontraction) was observed in all types of epidermolysis bullosa (EB). When contraction in control fibroblasts was defined as the mean ± 2 SD, (all control values were within this range) and the data were analyzed by the chi-square test, only 32% of EB cells fell within this range, with 47% poorly contractile and 21% hypercontractile. These data, derived from 34 patients, indicate that no single genetic defect resulting in altered contractility in the 3 distinct types of EB is likely. Neither cell viability, collagenase expression, nor PGE2 synthesis as correlated with gel contraction in any group. Indomethacin had no effect on contraction in RDEB. It is possible that the genetic defects in EB cause blister formation in vivo and may lead in some way to an abnormal interaction of fibroblasts with the extracellular matrix resulting in an altered collagen lattice contraction in vitro.
UR - http://www.scopus.com/inward/record.url?scp=0023197065&partnerID=8YFLogxK
U2 - 10.1111/1523-1747.ep12470412
DO - 10.1111/1523-1747.ep12470412
M3 - Article
C2 - 3035032
AN - SCOPUS:0023197065
SN - 0022-202X
VL - 88
SP - 741
EP - 746
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 6
ER -